Eric King

Eric King's work experience begins in 2006 as the VP of OEM Sales & Business Development at InnoPath Software. In 2012, they joined Intel Corporation as the Director of Strategic Business Development, focusing on Intel's Client and IoT businesses. Eric held this position until 2017.

After leaving Intel, Eric became an investor and board director at various companies, starting with Intel Capital in 2017. Eric later took on similar roles at Caresyntax, Retrace, eXo Imaging, Inc., and Medical Informatics Corp in 2021 and 2019 respectively.

In 2022, Eric became an investor and board director at Biofourmis and SaVia Health, followed by joining OXOS Medical in 2023 in the same capacity.

Eric King earned an MBA degree in Business Administration & Finance from Brigham Young University. No specific information regarding the start and end years of their education at this institution is available.